These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 24656928)
1. Early events in Sjögren's Syndrome pathogenesis: the importance of innate immunity in disease initiation. Kramer JM Cytokine; 2014 Jun; 67(2):92-101. PubMed ID: 24656928 [TBL] [Abstract][Full Text] [Related]
9. Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome. Srivastava A; Makarenkova HP Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271951 [TBL] [Abstract][Full Text] [Related]
10. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome. Matsumoto I; Tsubota K; Satake Y; Kita Y; Matsumura R; Murata H; Namekawa T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T J Clin Invest; 1996 Apr; 97(8):1969-77. PubMed ID: 8621782 [TBL] [Abstract][Full Text] [Related]
11. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands. Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863 [TBL] [Abstract][Full Text] [Related]
12. Role of dendritic cells in Sjögren's syndrome. Vogelsang P; Jonsson MV; Dalvin ST; Appel S Scand J Immunol; 2006 Sep; 64(3):219-26. PubMed ID: 16918690 [TBL] [Abstract][Full Text] [Related]
13. Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren's Syndrome. Shimizu T; Nakamura H; Kawakami A Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803026 [TBL] [Abstract][Full Text] [Related]
16. Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjögren's syndrome. Ainola M; Porola P; Takakubo Y; Przybyla B; Kouri VP; Tolvanen TA; Hänninen A; Nordström DC Clin Exp Immunol; 2018 Mar; 191(3):301-310. PubMed ID: 29105068 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome. Nakamura H; Kawakami A; Eguchi K Transl Res; 2006 Dec; 148(6):281-8. PubMed ID: 17162248 [TBL] [Abstract][Full Text] [Related]
19. B cell toll-like receptors with respect to the pathogenesis of Sjögren's syndrome. Berglová I; Krejsek J; Kolácková M; Slezák R Acta Medica (Hradec Kralove); 2011; 54(2):51-7. PubMed ID: 21842717 [TBL] [Abstract][Full Text] [Related]
20. Current and Emerging Evidence for Toll-Like Receptor Activation in Sjögren's Syndrome. Kiripolsky J; Kramer JM J Immunol Res; 2018; 2018():1246818. PubMed ID: 30671484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]